Skip to main content
Top

Cellular Oncology

Issue 6/2014

Content (7 Articles)

Original Paper

Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells

Qing Wu, Yong-Feng Chen, Jie Fu, Qi-Han You, Shou-Mei Wang, Xue Huang, Xiao-Jun Feng, Shu-Hui Zhang

Original Paper

E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells

Akhilesh Rawat, Gopal Gopisetty, Rajkumar Thangarajan

Original Paper

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation

Yan Li, Kai Wang, Yi-Zhou Jiang, Xin-Wen Chang, Cai-Feng Dai, Jing Zheng

Original Paper

Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways

Kumaravel Mohankumar, Sankar Pajaniradje, Subhashree Sridharan, Vivek Kumar Singh, Larance Ronsard, Akhil C. Banerjea, Benson Chellakkan Selvanesan, Mohane Selvaraj Coumar, Latha Periyasamy, Rukkumani Rajagopalan

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine